1 – 29 of 29
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Association between low selenoprotein P concentrations and anaemia in hospitalized heart failure patients
2024) In ESC Heart Failure(
- Contribution to journal › Article
-
Mark
Low levels of selenoprotein P associate with cognitive impairment in patients hospitalized for heart failure
2024) In Journal of Cardiac Failure(
- Contribution to journal › Article
- 2023
-
Mark
Immunoassay-based quantification of full-length peptidylglycine alpha-amidating monooxygenase in human plasma
(
- Contribution to journal › Article
-
Mark
Selenoprotein P deficiency is associated with higher risk of incident heart failure
(
- Contribution to journal › Article
- 2022
-
Mark
The effect of a randomised controlled lifestyle intervention on weight loss and plasma proneurotensin
(
- Contribution to journal › Article
-
Mark
Plasma Proneurotensin and Prediction of Cause-Specific Mortality in a Middle-aged Cohort During Long-term Follow-up
(
- Contribution to journal › Article
- 2021
-
Mark
Novel insights into peptide amidation and amidating activity in the human circulation
(
- Contribution to journal › Article
- 2020
-
Mark
Magnitude of rise in proneurotensin is related to amount of triglyceride appearance in blood after standardized oral intake of both saturated and unsaturated fat
(
- Contribution to journal › Article
- 2019
-
Mark
Seleno protein-P deficiency predicts cardiovascular disease and death
(
- Contribution to journal › Article
-
Mark
Proenkephalin a 119-159 (penKid) - a novel biomarker for acute kidney injury in sepsis : an observational study
(
- Contribution to journal › Article
-
Mark
Novel Methods for the Quantification of Dipeptidyl Peptidase 3 (DPP3) Concentration and Activity in Human Blood Samples
(
- Contribution to journal › Article
-
Mark
Selenoprotein P Deficiency and Risk of Mortality and Rehospitalization in Acute Heart Failure
(
- Contribution to journal › Letter
-
Mark
Bioactive adrenomedullin, proenkephalin A and clinical outcomes in an acute heart failure setting
(
- Contribution to journal › Article
- 2018
-
Mark
Proneurotensin Predicts Cardiovascular Disease in an Elderly Population
(
- Contribution to journal › Article
- 2017
-
Mark
Fasting levels of growth hormone are associated with carotid intima media thickness but are not affected by fluvastatin treatment
(
- Contribution to journal › Article
-
Mark
High Level of Fasting Plasma Proenkephalin-A Predicts Deterioration of Kidney Function and Incidence of CKD
(
- Contribution to journal › Article
- 2015
-
Mark
Diagnostic and short-term prognostic utility of plasma pro-enkephalin (pro-ENK) for acute kidney injury in patients admitted with sepsis in the emergency department
(
- Contribution to journal › Article
-
Mark
Stable Peptide of the Endogenous Opioid Enkephalin Precursor and Breast Cancer Risk.
(
- Contribution to journal › Article
- 2014
-
Mark
Fasting levels of high-sensitivity growth hormone predict cardiovascular morbidity and mortality: the malmö diet and cancer study.
(
- Contribution to journal › Article
-
Mark
Validation of plasma proneurotensin as a novel biomarker for the prediction of incident breast cancer.
(
- Contribution to journal › Article
- 2012
-
Mark
Vasoactive Peptides with Angiogenesis-Regulating Activity Predict Cancer Risk in Males.
2012) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 21(3). p.513-522(
- Contribution to journal › Article
-
Mark
Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer, and mortality.
(
- Contribution to journal › Article
- 2011
-
Mark
Prediction of Alzheimer's Disease Using Midregional Proadrenomedullin and Midregional Proatrial Natriuretic Peptide: A Retrospective Analysis of 134 Patients With Mild Cognitive Impairment
(
- Contribution to journal › Article
-
Mark
Antihypertensive Therapy Is Associated with Reduced Rate of Conversion to Alzheimer's Disease in Midregional Proatrial Natriuretic Peptide Stratified Subjects with Mild Cognitive Impairment
(
- Contribution to journal › Article
- 2010
-
Mark
Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation.
(
- Contribution to journal › Article
-
Mark
Plasma copeptin and the risk of diabetes mellitus.
(
- Contribution to journal › Article
- 2009
-
Mark
Distribution and Correlates of Midregional Proadrenomedullin in the General Population.
(
- Contribution to journal › Article
-
Mark
Novel and conventional biomarkers for prediction of incident cardiovascular events in the community.
(
- Contribution to journal › Article
-
Mark
Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure
(
- Contribution to journal › Article